Difference between revisions of "Team:Tongji China/Judging form"

 
(17 intermediate revisions by 3 users not shown)
Line 1: Line 1:
 
{{Tongji_China/Head_N_Prefix}}
 
{{Tongji_China/Head_N_Prefix}}
<html>
+
{{Tongji_China/userDefault}}
<link rel="stylesheet" type="text/css" href="https://2018.igem.org/Template:Tongji_China/userDefault?action=raw&ctype=text/css">
+
</html>
+
 
{{Tongji_China/Head_N_Suffix}}
 
{{Tongji_China/Head_N_Suffix}}
 
{{Tongji_China/Header_N}}
 
{{Tongji_China/Header_N}}
Line 13: Line 11:
 
<body>
 
<body>
 
<div class="background">
 
<div class="background">
 +
<div class="content">
 +
<div class="title">Achievement</div>
 +
<div class="logoPicture">
 +
<img src="https://static.igem.org/mediawiki/2018/5/50/T--Tongji_China--picture-judgingform-0.png" width="15%" height="25%" />
 +
</div>
 +
<div class="title_2">Judging Form</div>
 
<div class="judgeTitle" style="margin-top:auto;">
 
<div class="judgeTitle" style="margin-top:auto;">
Bronze medal
+
<br>Bronze medal
 
</div>
 
</div>
 
<div class="judgeTitle2">
 
<div class="judgeTitle2">
Line 20: Line 24:
 
</div>
 
</div>
 
<div class="content">
 
<div class="content">
We’ve successfully registered and will attend the Giant Jamboree.
+
We've successfully registered and will attend the Giant Jamboree.<br><br>
 
</div>
 
</div>
 
<div class="judgeTitle2">
 
<div class="judgeTitle2">
Line 26: Line 30:
 
</div>
 
</div>
 
<div class="content">
 
<div class="content">
We have clear attributions.<br>
+
We have clear attributions. See more details at<br>
<a href="https://2018.igem.org/Team:Tongji_China/Attributions">https://2018.igem.org/Team:Tongji_China/Attributions</a>
+
<a href="https://2018.igem.org/Team:Tongji_China/Attributions">https://2018.igem.org/Team:Tongji_China/Attributions</a><br><br>
 
</div>
 
</div>
 
<div class="judgeTitle2">
 
<div class="judgeTitle2">
Line 33: Line 37:
 
</div>
 
</div>
 
<div class="content">
 
<div class="content">
We’ve successfully participate in the 2018 InterLab Study.<br>
+
We've successfully participated in the 2018 InterLab Study.<br>
<a href="https://2018.igem.org/Team:Tongji_China/InterLab">https://2018.igem.org/Team:Tongji_China/InterLab</a>
+
<a href="https://2018.igem.org/Team:Tongji_China/InterLab">https://2018.igem.org/Team:Tongji_China/InterLab</a><br><br>
 
</div>
 
</div>
 
<div class="judgeTitle">
 
<div class="judgeTitle">
Line 43: Line 47:
 
</div>
 
</div>
 
<div class="content">
 
<div class="content">
We’ve made several new biobricks relating to T3SS and immunization therapy and successfully submitted them. The number of them are
+
We've made several new BioBricks relating to T3SS and cancer immunotherapy and successfully submitted them. The numbers of them are<br>
 +
                        <a href="https://2018.igem.org/Team:Tongji_China/Part">https://2018.igem.org/Team:Tongji_China/Part</a><br><br>
 
</div>
 
</div>
 
<div class="judgeTitle2">
 
<div class="judgeTitle2">
Line 49: Line 54:
 
</div>
 
</div>
 
<div class="content">
 
<div class="content">
We receive the assistance of ShanghaiTech, SJTU-BioX-Shanghai, SSTi-SZGD and CPU_CHINA. Also, we provide help to SDU-CHINA and SJTU-BioX-Shanghai.<br>
+
We receive the assistance of ShanghaiTech, SJTU-BioX-Shanghai, SSTi-SZGD and CPU_CHINA. Also, we provide help to SKLMT-China and SJTU-BioX-Shanghai.<br>
<a href="https://2018.igem.org/Team:Tongji_China/Collaborations">https://2018.igem.org/Team:Tongji_China/Collaborations</a>
+
<a href="https://2018.igem.org/Team:Tongji_China/Collaborations">https://2018.igem.org/Team:Tongji_China/Collaborations</a><br><br>
 
</div>
 
</div>
 
<div class="judgeTitle2">
 
<div class="judgeTitle2">
Line 56: Line 61:
 
</div>
 
</div>
 
<div class="content">
 
<div class="content">
We’ve done education work in high school and do some survey according to our projects.<br>
+
We’ve done education work in high school and some surveys according to our projects.<br>
<a href="https://2018.igem.org/Team:Tongji_China/Human_Practices">https://2018.igem.org/Team:Tongji_China/Human_Practices</a>
+
<a href="https://2018.igem.org/Team:Tongji_China/Human_Practices">https://2018.igem.org/Team:Tongji_China/Human_Practices</a><br><br>
 
</div>
 
</div>
 
<div class="judgeTitle">
 
<div class="judgeTitle">
Line 66: Line 71:
 
</div>
 
</div>
 
<div class="content">
 
<div class="content">
We’ve done survey both in society and in hospital and university. According to the attitude of the society and the advice of doctors and teachers, we made the further plan of our project. We’ve visited the Roche Co. and got the idea of our product.
+
We've done survey in range of society, hospitals and campus. According to the attitudes of the public and the advice from doctors and teachers, we've made further plans for our project. Besides, we've visited the Roche Co. and got the idea of our therapeutic product.
 
<br>
 
<br>
<a href="https://2018.igem.org/Team:Tongji_China/Human_Practices">https://2018.igem.org/Team:Tongji_China/Human_Practices</a>
+
<a href="https://2018.igem.org/Team:Tongji_China/Human_Practices">https://2018.igem.org/Team:Tongji_China/Human_Practices</a><br><br>
 
</div>
 
</div>
 
<div class="judgeTitle2">
 
<div class="judgeTitle2">
Line 74: Line 79:
 
</div>
 
</div>
 
<div class="content">
 
<div class="content">
We’ve made the model of the antigen and SNVs.<br>
+
We've made a model of the antigen and SNVs.<br>
<a href="https://2018.igem.org/Team:Tongji_China/Model">https://2018.igem.org/Team:Tongji_China/Model</a>
+
<a href="https://2018.igem.org/Team:Tongji_China/Model">https://2018.igem.org/Team:Tongji_China/Model</a><br><br>
 
</div>
 
</div>
 
<div class="judgeTitle2">
 
<div class="judgeTitle2">
Line 81: Line 86:
 
</div>
 
</div>
 
<div class="content">
 
<div class="content">
We’ve done a series of experiments to make sure that the antigen can be transferred into APCs and will trigger the immunological reaction.<br>
+
We've done a series of experiments to make sure that the antigens can be transferred into APCs and thus trigger the immunoreaction.<br>
<a href="https://2018.igem.org/Team:Tongji_China/Demonstrate">https://2018.igem.org/Team:Tongji_China/Demonstrate</a>
+
<a href="https://2018.igem.org/Team:Tongji_China/Demonstrate">https://2018.igem.org/Team:Tongji_China/Demonstrate</a><br><br>
 
</div>
 
</div>
 
</div>
 
</div>
 +
</div>
 
</body>
 
</body>
 
</html>
 
</html>
 +
{{Tongji_China/Footer_N}}

Latest revision as of 12:20, 17 October 2018

For Judges
Achievement
Judging Form

Bronze medal
Registration and Jamboree Attendance
We've successfully registered and will attend the Giant Jamboree.

Attributions
We have clear attributions. See more details at
https://2018.igem.org/Team:Tongji_China/Attributions

Characterization
We've successfully participated in the 2018 InterLab Study.
https://2018.igem.org/Team:Tongji_China/InterLab

Silver medal
Validated Part
We've made several new BioBricks relating to T3SS and cancer immunotherapy and successfully submitted them. The numbers of them are
https://2018.igem.org/Team:Tongji_China/Part

Collaboration
We receive the assistance of ShanghaiTech, SJTU-BioX-Shanghai, SSTi-SZGD and CPU_CHINA. Also, we provide help to SKLMT-China and SJTU-BioX-Shanghai.
https://2018.igem.org/Team:Tongji_China/Collaborations

Human Practices
We’ve done education work in high school and some surveys according to our projects.
https://2018.igem.org/Team:Tongji_China/Human_Practices

Gold medal
Integrated Human Practices
We've done survey in range of society, hospitals and campus. According to the attitudes of the public and the advice from doctors and teachers, we've made further plans for our project. Besides, we've visited the Roche Co. and got the idea of our therapeutic product.
https://2018.igem.org/Team:Tongji_China/Human_Practices

Model Your Project
We've made a model of the antigen and SNVs.
https://2018.igem.org/Team:Tongji_China/Model

Demonstration of Your Work
We've done a series of experiments to make sure that the antigens can be transferred into APCs and thus trigger the immunoreaction.
https://2018.igem.org/Team:Tongji_China/Demonstrate